Cytotoxicity

Cytotoxicity refers to the capacity of a substance or agent to cause damage or death to living cells, reflecting a critical parameter in pharmacology, toxicology, and biomedicine. It is distinct from cytostatic effects, which inhibit cell growth and proliferation without causing cell death. Cytotoxic agents can induce a range of cellular responses, including inhibition of cell growth, induction of apoptotic or necrotic cell death, and disruption of metabolic or structural cellular integrity. Assessing cytotoxicity is fundamental for evaluating the safety and efficacy of pharmaceutical compounds, chemicals, and biomaterials, as it helps predict potential adverse effects and guides therapeutic development.

Various assays—based on enzyme activity, membrane permeability, metabolic activity, or cell proliferation—are routinely employed to characterize and quantify cytotoxic effects in vitro, providing essential insights into cell viability and the mechanisms underlying toxic responses.

Morphological types of cell toxicity are classified into three main categories—apoptosis, autophagy, and necrosis—each with distinct structural and mechanistic features.

Apoptosis (type I cell death) is characterized by nuclear condensation, cell shrinkage, membrane blebbing, and the formation of apoptotic bodies, typically cleared by phagocytosis. This regulated process involves signaling pathways leading to the activation of caspases and DNA fragmentation. Autophagy-dependent cell death (type II) shows cytoplasmic vacuolization with abundant autophagosomes, mild nuclear changes, and typically involves catabolic processes to degrade cellular organelles via the lysosomal pathway. Necrosis (type III), in contrast, is marked by swelling of organelles and the plasma membrane, culminating in membrane rupture and the uncontrolled release of cellular contents, often resulting in inflammation; it is generally associated with acute, severe injury that disrupts cell homeostasis and energetics, such as ATP depletion or loss of membrane integrity.

Advances have expanded this framework to include mechanistically distinct forms like necroptosis, pyroptosis, and ferroptosis, each with unique morphological hallmarks but often overlapping features, underlining the complexity and evolving nature of the classification of cell toxicity.

Cells undergoing necrosis typically swell rapidly, lose membrane integrity, shut down metabolism, and release their contents into the surrounding environment. In vitro, rapid necrosis does not allow sufficient time or energy for activation of apoptotic pathways, and such cells therefore fail to express apoptotic markers. By contrast, apoptosis is defined by characteristic cytological and molecular events, including changes in the cell's refractive index, cytoplasmic shrinkage, nuclear condensation, and fragmentation of DNA into regularly sized pieces. In culture, apoptotic cells eventually progress to secondary necrosis, at which point they lose membrane integrity, cease metabolism, and undergo lysis.

Cytotoxicity assays are widely used in the pharmaceutical industry to evaluate compounds for cytotoxic effects. In drug discovery, researchers may screen for cytotoxic compounds when developing therapeutics that target rapidly dividing cancer cells, or conversely, assess initial "hits" from high-throughput screens to exclude those with unwanted cytotoxicity before further development.

One of the most common approaches is to assess cell membrane integrity. Healthy cells exclude vital dyes such as trypan blue or propidium iodide, whereas damaged membranes allow these dyes to enter and stain intracellular components. Conversely, intracellular molecules may leak into the culture medium when membrane integrity is lost. A widely used example is the lactate dehydrogenase (LDH) assay, in which LDH released from damaged cells reduces NAD to NADH, producing a detectable color change with a specific probe. Protease-based biomarkers can also distinguish live and dead cells within the same population. The live-cell protease remains active only in cells with intact membranes, while the dead-cell protease is detectable in the medium only after membrane disruption.